<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01417351</url>
  </required_header>
  <id_info>
    <org_study_id>217516</org_study_id>
    <nct_id>NCT01417351</nct_id>
  </id_info>
  <brief_title>Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune Function</brief_title>
  <official_title>Assessment of Inflammatory Markers and Pregnancy Outcomes in Vitamin D-Supplemented Women at Risk of Vitamin D Deficiency: A Double-Blind, Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>USDA, Western Human Nutrition Research Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>USDA, Western Human Nutrition Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers at the USDA Western Human Nutrition Research Center and clinicians at UC Davis
      Medical Center are currently conducting a study on the effects of vitamin D supplementation
      during pregnancy on maternal health and immune function. The investigators believe that
      vitamin D supplementation at levels greater than the current recommendation is beneficial for
      maternal health during pregnancy. In particular, there is evidence that vitamin D deficiency
      during pregnancy puts women at greater risk for diseases like pre-eclampsia, which may be due
      to an imbalance in immune function at the placenta. This randomized, double-blind study is
      designed to test this hypothesis. Pregnant women who participate in the study receive either
      400 IU or 2,000 IU of vitamin D per day for the duration of their pregnancy. The
      investigators will collect blood at three time points during pregnancy (16-20 weeks, 26-28
      weeks, 36 weeks gestation) for analysis of immune function and vitamin D status. The
      investigators are also collecting data on clinical parameters, such as blood pressure and
      glucose tolerance.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in T-cell cytokine expression</measure>
    <time_frame>16-20 wks, 26-28 wks, and 36 wks gestation</time_frame>
    <description>Inflammatory and regulatory cytokines will be measured in cultured T-cells by flow cytometry.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Vitamin D status</measure>
    <time_frame>16-20 wks, 26-28 wks, 36 wks gestation</time_frame>
    <description>Serum 25-OH vitamin D and 1, 25 (OH)2 Vitamin D</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in innate immune function</measure>
    <time_frame>16-20 wks, 26-28 wks, 36 wks gestation</time_frame>
    <description>Monocyte and NK cell cytokine expression and response to stimulation with Toll-like Receptor agonists.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>16-20 wks, 26-28 wks, 36 wks gestation</time_frame>
    <description>Blood pressure will be measured using standard techniques.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>400 IU Vitamin D3</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Women in this study arm receive 400 IU of vitamin D3 per day, or what is in a standard prenatal multivitamin. They also receive a placebo study supplement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2,000 IU Vitamin D3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Women in this arm receive 2,000 IU vitamin D per day: 400 IU from a standard prenatal multivitamin plus an additional 1,600 IU vitamin D3 in the study supplement.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>400 IU vitamin D3</intervention_name>
    <description>Women in this study arm receive 400 IU of vitamin D3 per day, or what is in a standard prenatal multivitamin. They also receive a placebo study supplement.</description>
    <arm_group_label>400 IU Vitamin D3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>2,000 IU Vitamin D3</intervention_name>
    <description>Women in this arm receive 2,000 IU vitamin D per day: 400 IU from a standard prenatal multivitamin plus an additional 1,600 IU vitamin D3 in the study supplement.</description>
    <arm_group_label>2,000 IU Vitamin D3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women

          -  Less than 20 weeks gestation

          -  Over 18 years of age

          -  Able to swallow nutritional supplements

        Exclusion Criteria:

          -  Use of medications known to affect vitamin D metabolism

          -  Diagnosis of type 1 diabetes

          -  History of thyroid, renal, or liver disease

          -  Problems with digestion or absorption
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles B Stephensen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>USDA, ARS, Western Human Nutrition Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>USDA-Western Human Nutrition Research Center</name>
      <address>
        <city>Davis</city>
        <state>California</state>
        <zip>95616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center Obstetrics &amp; Gynecology</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 12, 2011</study_first_submitted>
  <study_first_submitted_qc>August 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 16, 2011</study_first_posted>
  <last_update_submitted>July 22, 2013</last_update_submitted>
  <last_update_submitted_qc>July 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pregnancy</keyword>
  <keyword>immune function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

